The trademark application GWYN was filed by Mylan Pharmaceuticals Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on July 18, 2022, and it was registered by office on October 25, 2022 without any oppositions.
The application was filed in English (German was selected as the second language).
Goods And Services
The mark was filed in class 5 with following description of goods:
Pharmaceutical preparations for the treatment of multiple sclerosis
Pharmaceutical preparations for the treatment of neurological disorders
Pharmaceuticals for the treatment of diseases and disorders of the central nervous system